“…The increased sympathetic activity is related to the risk of life (Marmar & Shivkumar, 2008), and interventions that decrease this activity reduce mortality from cardiovascular disease (ESC, 1996). In this context, TENS is presented as a potential therapeutic resource able to interact in different clinical conditions, such as hypertension, in addition to its analgesic effects widely described in literature (Chesterton et al, 2002;Sbruzzi et al, 2012;Vance et al, 2014;Bi et al, 2015). This interaction of TENS with the cardiovascular system is demonstrated by vasodilation (Cramp et al, 2000;Miller, Gruben, & Morgan, 2000;Sherry et al, 2001;Vieira et al, 2012), increased blood in peripheral and coronary blood flow (Chauhan et al, 1994;Jessurun et al, 1998;Cramp et al, 2000;Miller et al, 2000;Sandberg, Sandberg, & Dahl, 2007), decreased peripheral vascular resistance (Mannheimer, Emanuelsson, & Waagstein, 1990;Sherry et al, 2001), and heart rate (Nitz, 2003).…”